HALEON PLC-ADR (HLN) Fundamental Analysis & Valuation

NYSE:HLNUS4055521003

Current stock price

9.99 USD
+0.02 (+0.2%)
Last:

This HLN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. HLN Profitability Analysis

1.1 Basic Checks

  • HLN had positive earnings in the past year.
  • HLN had a positive operating cash flow in the past year.
  • In the past 5 years HLN has always been profitable.
  • HLN had a positive operating cash flow in each of the past 5 years.
HLN Yearly Net Income VS EBIT VS OCF VS FCFHLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.11%, HLN belongs to the top of the industry, outperforming 85.94% of the companies in the same industry.
  • HLN has a better Return On Equity (10.15%) than 84.38% of its industry peers.
  • The Return On Invested Capital of HLN (7.04%) is better than 83.85% of its industry peers.
  • HLN had an Average Return On Invested Capital over the past 3 years of 6.87%. This is significantly below the industry average of 13.06%.
  • The last Return On Invested Capital (7.04%) for HLN is above the 3 year average (6.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROIC 7.04%
ROA(3y)4.13%
ROA(5y)3.89%
ROE(3y)8.46%
ROE(5y)7.43%
ROIC(3y)6.87%
ROIC(5y)6.44%
HLN Yearly ROA, ROE, ROICHLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • HLN has a Profit Margin of 15.11%. This is amongst the best in the industry. HLN outperforms 88.54% of its industry peers.
  • In the last couple of years the Profit Margin of HLN has grown nicely.
  • HLN has a Operating Margin of 22.78%. This is amongst the best in the industry. HLN outperforms 89.06% of its industry peers.
  • In the last couple of years the Operating Margin of HLN has remained more or less at the same level.
  • The Gross Margin of HLN (65.01%) is better than 71.88% of its industry peers.
  • In the last couple of years the Gross Margin of HLN has remained more or less at the same level.
Industry RankSector Rank
OM 22.78%
PM (TTM) 15.11%
GM 65.01%
OM growth 3Y0.53%
OM growth 5Y0.46%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.63%
GM growth 5Y1.07%
HLN Yearly Profit, Operating, Gross MarginsHLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. HLN Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HLN is destroying value.
  • The number of shares outstanding for HLN has been reduced compared to 1 year ago.
  • HLN has less shares outstanding than it did 5 years ago.
  • HLN has a better debt/assets ratio than last year.
HLN Yearly Shares OutstandingHLN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
HLN Yearly Total Debt VS Total AssetsHLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 2.50 indicates that HLN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of HLN (2.50) is better than 65.10% of its industry peers.
  • HLN has a debt to FCF ratio of 3.87. This is a good value and a sign of high solvency as HLN would need 3.87 years to pay back of all of its debts.
  • The Debt to FCF ratio of HLN (3.87) is better than 87.50% of its industry peers.
  • HLN has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • HLN has a Debt to Equity ratio of 0.47. This is in the lower half of the industry: HLN underperforms 61.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.87
Altman-Z 2.5
ROIC/WACC0.83
WACC8.48%
HLN Yearly LT Debt VS Equity VS FCFHLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • HLN has a Current Ratio of 0.92. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.92, HLN is not doing good in the industry: 86.46% of the companies in the same industry are doing better.
  • HLN has a Quick Ratio of 0.92. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HLN's Quick ratio of 0.71 is on the low side compared to the rest of the industry. HLN is outperformed by 85.42% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.71
HLN Yearly Current Assets VS Current LiabilitesHLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

3

3. HLN Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.59% over the past year.
  • HLN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.56% yearly.
  • Looking at the last year, HLN shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
  • Measured over the past years, HLN shows a small growth in Revenue. The Revenue has been growing by 5.78% on average per year.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%280.16%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.38% on average over the next years.
  • Based on estimates for the next years, HLN will show a small growth in Revenue. The Revenue will grow by 3.26% on average per year.
EPS Next Y6.33%
EPS Next 2Y8.54%
EPS Next 3Y8.95%
EPS Next 5Y7.38%
Revenue Next Year-1.37%
Revenue Next 2Y0.95%
Revenue Next 3Y2.1%
Revenue Next 5Y3.26%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HLN Yearly Revenue VS EstimatesHLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
HLN Yearly EPS VS EstimatesHLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.1 0.2 0.3 0.4 0.5

6

4. HLN Valuation Analysis

4.1 Price/Earnings Ratio

  • HLN is valuated rather expensively with a Price/Earnings ratio of 20.39.
  • 82.81% of the companies in the same industry are more expensive than HLN, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of HLN to the average of the S&P500 Index (26.91), we can say HLN is valued slightly cheaper.
  • With a Price/Forward Earnings ratio of 17.42, HLN is valued on the expensive side.
  • HLN's Price/Forward Earnings ratio is rather cheap when compared to the industry. HLN is cheaper than 80.21% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.69. HLN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.39
Fwd PE 17.42
HLN Price Earnings VS Forward Price EarningsHLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • HLN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HLN is cheaper than 82.81% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, HLN is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.87
EV/EBITDA 14.01
HLN Per share dataHLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLN does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of HLN may justify a higher PE ratio.
PEG (NY)3.22
PEG (5Y)1.16
EPS Next 2Y8.54%
EPS Next 3Y8.95%

5

5. HLN Dividend Analysis

5.1 Amount

  • HLN has a Yearly Dividend Yield of 1.94%.
  • HLN's Dividend Yield is rather good when compared to the industry average which is at 0.64. HLN pays more dividend than 92.19% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, HLN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.94%

5.2 History

  • HLN has been paying a dividend for at least 10 years, so it has a reliable track record.
  • HLN has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
HLN Yearly Dividends per shareHLN Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.05 0.1 0.15 0.2

5.3 Sustainability

  • HLN pays out 36.71% of its income as dividend. This is a sustainable payout ratio.
DP36.71%
EPS Next 2Y8.54%
EPS Next 3Y8.95%
HLN Yearly Income VS Free CF VS DividendHLN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
HLN Dividend Payout.HLN Dividend Payout, showing the Payout Ratio.HLN Dividend Payout.PayoutRetained Earnings

HLN Fundamentals: All Metrics, Ratios and Statistics

HALEON PLC-ADR

NYSE:HLN (4/9/2026, 12:04:46 PM)

9.99

+0.02 (+0.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-25
Earnings (Next)04-29
Inst Owners60.22%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap44.49B
Revenue(TTM)11.23B
Net Income(TTM)1.67B
Analysts80
Price Target11.91 (19.22%)
Short Float %0.37%
Short Ratio1.92
Dividend
Industry RankSector Rank
Dividend Yield 1.94%
Yearly Dividend0.18
Dividend Growth(5Y)N/A
DP36.71%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-10
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-1.69%
Revenue beat(4)0
Avg Revenue beat(4)-3.44%
Min Revenue beat(4)-4.82%
Max Revenue beat(4)-1.69%
Revenue beat(8)0
Avg Revenue beat(8)-3.28%
Revenue beat(12)1
Avg Revenue beat(12)-2.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.06%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.32%
EPS NY rev (3m)-1.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 20.39
Fwd PE 17.42
P/S 2.99
P/FCF 14.87
P/OCF 12.54
P/B 2.01
P/tB N/A
EV/EBITDA 14.01
EPS(TTM)0.49
EY4.9%
EPS(NY)0.57
Fwd EY5.74%
FCF(TTM)0.67
FCFY6.72%
OCF(TTM)0.8
OCFY7.98%
SpS3.34
BVpS4.97
TBVpS-2.78
PEG (NY)3.22
PEG (5Y)1.16
Graham Number7.4
Profitability
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROCE 9.07%
ROIC 7.04%
ROICexc 7.4%
ROICexgc 256.74%
OM 22.78%
PM (TTM) 15.11%
GM 65.01%
FCFM 20.14%
ROA(3y)4.13%
ROA(5y)3.89%
ROE(3y)8.46%
ROE(5y)7.43%
ROIC(3y)6.87%
ROIC(5y)6.44%
ROICexc(3y)7.38%
ROICexc(5y)6.79%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.85%
ROCE(5y)8.36%
ROICexgc growth 3Y31.03%
ROICexgc growth 5Y32.63%
ROICexc growth 3Y5.68%
ROICexc growth 5Y5.43%
OM growth 3Y0.53%
OM growth 5Y0.46%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.63%
GM growth 5Y1.07%
F-Score8
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.87
Debt/EBITDA 2.71
Cap/Depr 114.72%
Cap/Sales 3.74%
Interest Coverage 7.04
Cash Conversion 91.68%
Profit Quality 133.23%
Current Ratio 0.92
Quick Ratio 0.71
Altman-Z 2.5
F-Score8
WACC8.48%
ROIC/WACC0.83
Cap/Depr(3y)107.2%
Cap/Depr(5y)109.42%
Cap/Sales(3y)3.18%
Cap/Sales(5y)3.14%
Profit Quality(3y)146.3%
Profit Quality(5y)135.74%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%280.16%
EPS Next Y6.33%
EPS Next 2Y8.54%
EPS Next 3Y8.95%
EPS Next 5Y7.38%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%
Revenue Next Year-1.37%
Revenue Next 2Y0.95%
Revenue Next 3Y2.1%
Revenue Next 5Y3.26%
EBIT growth 1Y-1.26%
EBIT growth 3Y1.06%
EBIT growth 5Y2.67%
EBIT Next Year20.78%
EBIT Next 3Y10.91%
EBIT Next 5Y9.2%
FCF growth 1Y12%
FCF growth 3Y8.58%
FCF growth 5Y15.32%
OCF growth 1Y14.47%
OCF growth 3Y8.49%
OCF growth 5Y13.36%

HALEON PLC-ADR / HLN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?

ChartMill assigns a fundamental rating of 6 / 10 to HLN.


What is the valuation status of HALEON PLC-ADR (HLN) stock?

ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.


Can you provide the profitability details for HALEON PLC-ADR?

HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.


What is the financial health of HALEON PLC-ADR (HLN) stock?

The financial health rating of HALEON PLC-ADR (HLN) is 5 / 10.


Can you provide the dividend sustainability for HLN stock?

The dividend rating of HALEON PLC-ADR (HLN) is 5 / 10 and the dividend payout ratio is 36.71%.